+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood Collection Market Analysis by Product (Blood Bags, Needles and Syringes, Blood Collection Tubes), by Application (Treatment, Diagnostics), by End User (Blood Banks, Hospitals, Diagnostics Centers), and by Region - Forecast to 2029

  • PDF Icon

    Report

  • 143 Pages
  • June 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5607049
The global blood collection market size is estimated to be USD 5.92 billion in 2021 and is expected to witness a CAGR of 6.42% during the forecast period. Rise in demand for plasma due to growing cases of COVID 19 globally is a key driver for the growth of the global blood collection market. Additionally, increase in global number of accidents & trauma cases and occurrence of liquid biopsy tests are some of the other drivers propelling the market growth. Nevertheless, high price of automated blood collection devices and risks related with blood transfusions are expected to restrain the global market growth.

By Product


Based on product, the market is segmented into blood bags, needles and syringes, blood collection tubes, and others. In 2021, the needles and syringes segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in adoption of needles and syringes, recurring buying, and high affordability of needles worldwide. Blood bags segment projected to grow at a profitable CAGR during the forecast period. This is attributed to worldwide increase in the number of surgeries and accidents along with rise in number of blood transfusions and donations.

By Application


Based on application, the market is segmented into treatment and diagnostics. In 2021, the diagnostics segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in occurrence of chronic diseases such as diabetes, cancer, and cardiovascular diseases worldwide. Treatment segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing need for plasma due to growing cases of COVID 19 globally which requires prompt and precise treatment.

By End User


Based on end user, the market is categorized into blood banks, hospitals, diagnostics centers, and others. In 2021, the hospitals segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the fact that hospitals act as prime centers for treatment and diagnosis of diseases as the number of chronic diseases rising worldwide. The diagnostics centers is anticipated to grow at a profitable CAGR during the forecast period, due to the increasing accessibility of sophisticated equipment that allows in obtaining faster results.

Regional Insights


In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major players in the region, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from government for driving various blood donation camps, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the increase in disposable income, growing government and corporate investment in healthcare sector, rise in presence of major players in this region, are the major factors in this region. Competitor Insights Some of the key players in the blood collection market are Becton, Dickinson and Company (U.S.); Haematonics (U.S.); Terumo BCT (Japan); Fresenius Kabi AG (Germany); Grifols (Spain); Nipro Medical Corporation (Japan); Greiner Holding (Austria); Quest Diagnostics (U.S.); SARSTEDT AG & Co. (Germany); Macopharma (France); Smith’s Medical (U.S.); Kawasumi Laboratories (Japan); Retractable Technologies (U.S.); and LiuyangSanli Medical Technology Development (China). The leading players operating in the blood collection industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The blood collection market report is categorized into the following segments and subsegments:

Blood Collection Market, By Product (Revenue, USD Billion, 2021 - 2029)

  • Blood Bags
  • Needles and Syringes

Blood Collection Tubes

  • Serum-separating
  • EDTA
  • Heparin
  • Plasma-separating
  • Others

Blood Collection Market, By Application (Revenue, USD Billion, 2021 - 2029)

  • Treatment
  • Diagnostics

Blood Collection Market, By End User (Revenue, USD Billion, 2021 - 2029)

  • Blood banks
  • Hospitals
  • Diagnostics centers
  • Others

Blood Collection Market, By Region (Revenue, USD Billion, 2021 - 2029)


North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
1.4.1. Research Models
1.4.1.1. Bottom-up Approach
1.4.1.2. Top-down Approach
1.4.1.3. Data Triangulation
1.4.2. Data Procurement
1.4.2.1. Internal Database
1.4.2.2. Secondary Research
1.4.2.3. Purchased Database
1.4.2.4. Primary Research
1.4.3. Data Analysis
1.4.3.1. Data Validation
1.4.3.2. Market Size Estimation
1.4.3.3. Market Forecast Model
1.4.4. Quality Assessment
2. Introduction: Blood Collection
3. Executive Summary
3.1. Global Market Scenario
3.2. Segment Market Scenario
3.3. Geographic Market Scenario
3.4. COVID-19 Impact
3.5. Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4
5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. Value Chain Analysis
5.4. SWOT Analysis
5.5. Benchmark
6. COVID-19 Impact Analysis: Blood Collection Market
6.1. COVID-19: Overview
6.2. COVID-19 Impact on the Global Market
6.3. COVID-19 Impact on the Regional Markets
7. Market Analysis by Product
7.1. Blood Bags
7.1.1. Blood Bags Market Forecast, 2021-2029 (USD Million)
7.2. Needles and Syringes
7.2.1. Needles and Syringes Market Forecast, 2021-2029 (USD Million)
7.3. Blood Collection Tubes
7.3.1. Blood Collection Tubes Market Forecast, 2021-2029 (USD Million)
7.4. Others
7.4.1. Others Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Application
8.1. Treatment
8.1.1. Treatment Market Forecast, 2021-2029 (USD Million)
8.2. Diagnostics
8.2.1. Diagnostics Market Forecast, 2021-2029 (USD Million)
9. Market Analysis by End User
9.1. Blood banks
9.1.1. Blood banks Market Forecast, 2021-2029 (USD Million)
9.2. Hospitals
9.2.1. Hospitals Market Forecast, 2021-2029 (USD Million)
9.3. Diagnostics centres
9.3.1. Diagnostics centres Market Forecast, 2021-2029 (USD Million)
9.4. Others
9.4.1. Others Market Forecast, 2021-2029 (USD Million)
10. Regional Market Analysis
10.1. Regional Market Trends
10.2. Regional Market: Comparative Analysis
11. North America Blood Collection Market
11.1. North America Blood Collection Market
11.1.1. North America Market Size and Forecast, 2021-2029 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
11.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
11.2. U.S. Blood Collection Market
11.2.1. U.S. Market Size and Forecast, 2021-2029 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
11.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
11.3. Canada Blood Collection Market
11.3.1. Canada Market Size and Forecast, 2021-2029 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
11.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12. Europe Blood Collection Market
12.1. Europe Blood Collection Market
12.1.1. Europe Market Size and Forecast, 2021-2029 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.2. Germany Blood Collection Market
12.2.1. Germany Market Size and Forecast, 2021-2029 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.3. UK Blood Collection Market
12.3.1. UK Market Size and Forecast, 2021-2029 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.4. France Blood Collection Market
12.4.1. France Market Size and Forecast, 2021-2029 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.4.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.4.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.5. Spain Blood Collection Market
12.5.1. Spain Market Size and Forecast, 2021-2029 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.5.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.5.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.6. Italy Blood Collection Market
12.6.1. Italy Market Size and Forecast, 2021-2029 (USD Million)
12.6.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.6.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.6.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
12.7. Rest of Europe Blood Collection Market
12.7.1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
12.7.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.7.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
12.7.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13. Asia Pacific Blood Collection Market
13.1. Asia Pacific Blood Collection Market
13.1.1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.2. Japan Blood Collection Market
13.2.1. Japan Market Size and Forecast, 2021-2029 (USD Million)
13.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.3. China Blood Collection Market
13.3.1. China Market Size and Forecast, 2021-2029 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.4. India Blood Collection Market
13.4.1. India Market Size and Forecast, 2021-2029 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.4.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.4.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.5. South Korea Blood Collection Market
13.5.1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
13.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.5.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.5.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.6. Australia Blood Collection Market
13.6.1. Australia Market Size and Forecast, 2021-2029 (USD Million)
13.6.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.6.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.6.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
13.7. Rest of Asia Pacific Blood Collection Market
13.7.1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
13.7.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.7.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
13.7.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14. Latin America Blood Collection Market
14.1. Latin America Blood Collection Market
14.1.1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
14.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14.2. Brazil Blood Collection Market
14.2.1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
14.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14.3. Mexico Blood Collection Market
14.3.1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
14.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14.4. Argentina Blood Collection Market
14.4.1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
14.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.4.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.4.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
14.5. Rest of Latin America Blood Collection Market
14.5.1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
14.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.5.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
14.5.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
15. MEA Blood Collection Market
15.1. MEA Blood Collection Market
15.1.1. MEA Market Size and Forecast, 2021-2029 (USD Million)
15.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
15.1.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
15.1.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
15.2. GCC Blood Collection Market
15.2.1. GCC Market Size and Forecast, 2021-2029 (USD Million)
15.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
15.2.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
15.2.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
15.3. South Africa Blood Collection Market
15.3.1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
15.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
15.3.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
15.3.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
15.4. Rest of MEA Blood Collection Market
15.4.1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
15.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
15.4.1.2. Market Size and Forecast by Application, 2021-2029 (USD Million)
15.4.1.3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
16. Competitor Analysis
16.1. Market Share Analysis, 2021 & 2029
16.2. Competitive Mapping
16.3. Key Players Market Place Analysis
16.4. Major Recent Developments
17. Company Profiles
17.1. Becton, Dickinson and Company (U.S.)
17.1.1. Company Snapshot
17.1.2. Company Overview
17.1.3. Financials
17.1.4. Application Benchmarking
17.1.5. Recent Developments
17.2. Haematonics (U.S.)
17.2.1. Company Snapshot
17.2.2. Company Overview
17.2.3. Financials
17.2.4. Application Benchmarking
17.2.5. Recent Developments
17.3. Terumo BCT (Japan)
17.3.1. Company Snapshot
17.3.2. Company Overview
17.3.3. Financials
17.3.4. Application Benchmarking
17.3.5. Recent Developments
17.4. Fresenius Kabi AG (Germany)
17.4.1. Company Snapshot
17.4.2. Company Overview
17.4.3. Financials
17.4.4. Application Benchmarking
17.4.5. Recent Developments
17.5. Grifols (Spain)
17.5.1. Company Snapshot
17.5.2. Company Overview
17.5.3. Financials
17.5.4. Application Benchmarking
17.5.5. Recent Developments
17.6. Nipro Medical Corporation (Japan)
17.6.1. Company Snapshot
17.6.2. Company Overview
17.6.3. Financials
17.6.4. Application Benchmarking
17.6.5. Recent Developments
17.7. Greiner Holding (Austria)
17.7.1. Company Snapshot
17.7.2. Company Overview
17.7.3. Financials
17.7.4. Application Benchmarking
17.7.5. Recent Developments
17.8. Quest Diagnostics (U.S.)
17.8.1. Company Snapshot
17.8.2. Company Overview
17.8.3. Financials
17.8.4. Application Benchmarking
17.8.5. Recent Developments
17.9. Macopharma (France)
17.9.1. Company Snapshot
17.9.2. Company Overview
17.9.3. Financials
17.9.4. Application Benchmarking
17.9.5. Recent Developments
17.10. Smith’s Medical (U.S.)
17.10.1. Company Snapshot
17.10.2. Company Overview
17.10.3. Financials
17.10.4. Application Benchmarking
17.10.5. Recent Developments
17.11. Kawasumi Laboratories (Japan)
17.11.1. Company Snapshot
17.11.2. Company Overview
17.11.3. Financials
17.11.4. Product Benchmarking
17.11.5. Recent Developments
17.12. Retractable Technologies (U.S.)
17.12.1. Company Snapshot
17.12.2. Company Overview
17.12.3. Financials
17.12.4. Product Benchmarking
17.12.5. Recent Developments
17.13. LiuyangSanli Medical Technology Development (China)
17.13.1. Company Snapshot
17.13.2. Company Overview
17.13.3. Financials
17.13.4. Product Benchmarking
17.13.5. Recent Developments
17.14. Company 14
17.14.1. Company Snapshot
17.14.2. Company Overview
17.14.3. Financials
17.14.4. Product Benchmarking
17.14.5. Recent Developments
17.15. Company 15
17.15.1. Company Snapshot
17.15.2. Company Overview
17.15.3. Financials
17.15.4. Product Benchmarking
17.15.5. Recent Developments
17.16. Others Prominent Players
18. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Becton
  • Dickinson and Company (U.S.)
  • Haematonics (U.S.)
  • Terumo BCT (Japan)
  • Fresenius Kabi AG (Germany)
  • Grifols (Spain)
  • Nipro Medical Corporation (Japan)
  • Greiner Holding (Austria)
  • Quest Diagnostics (U.S.)
  • SARSTEDT AG & Co. (Germany)
  • Macopharma (France)
  • Smith’s Medical (U.S.)
  • Kawasumi Laboratories (Japan)
  • Retractable Technologies (U.S.)
  • LiuyangSanli Medical Technology Development (China)